Key result
Axial LVAD sustains survival for ~6 years without anticoagulation in an advanced heart failure patient.
Case Report (n=1)
This case report demonstrates the potential feasibility of long-term LVAD support without anticoagulation in a specific patient with systemic lupus erythematosus.
Answers are grounded in this paper and cite their sources.
May inform select SLE cases; leaves open generalizability and should not change practice.
Left-ventricular assist devices (LVAD) are increasingly used for advanced heart failure [1–7]. LVAD implantation in patients with systemic lupus erythematosus (SLE) appears to be useful despite the possibility of gastrointestinal bleeding (GIB) complications. This case report highlights the first ever long term use of an axial continuous flow pump for >6 years without anticoagulation in a SLE patient who could not tolerate anticoagulation due to severe GIB complications. This case is interesting in that SLE in the advanced heart failure population is not well studied and confers significant morbidity and mortality on the whole.
No takes yet. Share an insight, caveat, or question.
Ray et al. (2023) conducted a case report in Advanced heart failure and systemic lupus erythematosus (SLE) (n=1). Axial continuous flow pump (LVAD) without anticoagulation was evaluated on Long-term use of LVAD without anticoagulation. Long-term use of an axial continuous flow pump for >6 years without anticoagulation was successfully achieved in a patient with systemic lupus erythematosus and advanced heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: